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Homo sapiens Systemic RNA Interference-defective-1
Transmembrane Family Member 1 (SIDT1) Protein Mediates
Contact-dependent Small RNA Transfer and
MicroRNA-21-driven Chemoresistance*□S
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From ‡Clinical Surgery, University of Edinburgh, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, Scotland, United Kingdom and
the §Pancreatic Cancer Biology Group, Edinburgh Cancer Research UK Centre, Institute of Genetics andMolecular Medicine,
Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, Scotland, United Kingdom
Background: The SID family is a highly conserved group of transmembrane channel-like proteins.
Results: SIDT1 facilitates rapid contact-dependent intercellular small RNA transfer and mediates chemoresistance driven by
microRNA-21 in human adenocarcinoma cells.
Conclusion: By mediating small RNA transfer, SIDT1 contributes to cancer chemoresistance mechanisms.
Significance: A better understanding of non-cell-autonomous RNA-based intercellular communication may yield novel anti-
cancer therapeutics.
Locally initiated RNA interference (RNAi) has the potential
for spatial propagation, inducing posttranscriptional gene
silencing in distant cells. In Caenorhabditis elegans, systemic
RNAi requires a phylogenetically conserved transmembrane
channel, SID-1. Here, we show that a human SID-1 orthologue,
SIDT1, facilitates rapid, contact-dependent, bidirectional small
RNA transfer between human cells, resulting in target-specific
non-cell-autonomous RNAi. Intercellular small RNA transfer
can be both homotypic and heterotypic.We show SIDT1-medi-
ated intercellular transfer of microRNA-21 to be a driver of
resistance to the nucleoside analog gemcitabine in human ade-
nocarcinoma cells. Documentation of a SIDT1-dependent small
RNA transfer mechanism and the associated phenotypic effects
on chemoresistance in human cancer cells raises the possibility
that conserved systemicRNAi pathways contribute to the acqui-
sition of drug resistance. Mediators of non-cell-autonomous
RNAi may be tractable targets for novel therapies aimed at
improving the efficacy of current cytotoxic agents.
RNA interference (RNAi) is initiated locally by double-
stranded RNA (dsRNA) but has the capacity to propagate sys-
temically (sysRNAi),2 inducing non-cell-autonomous posttran-
scriptional gene silencing in distant cells. Although best
described as an antiviral mechanism in plants (1–3), sysRNAi
also occurs in animals (4). In Caenorhabditis elegans, sysRNAi
is dependent on a member of the systemic RNA interference-
defective (SID) family of channels, SID-1 (5). SID-1 was initially
identified following a screen of C. elegans mutants lacking the
wild-type sysRNAi phenotype (5, 6).However, a range of organ-
isms, including mice and humans, exhibit striking SID gene
conservation (7–9).
SID channels have relative specificity for small RNA mole-
cules (10, 11). Although organism-wide sysRNAi phenomena
are not apparent inmammals, both SID-1 and its human ortho-
logue SIDT1 (SID-1 transmembrane family member 1) have
been shown to facilitate small interfering RNA (siRNA) uptake
in human systems (12–14). The increased uptake of extracellu-
lar siRNA into human cells that SIDT1 mediates can result in
highly specific posttranscriptional gene silencing (12, 13). We
previously demonstrated that SIDT1 functions as a transmem-
brane channel for siRNA and localizes to the plasmamembrane
in human cells (12). This observation led us to hypothesize that
SIDT1might also play a role in the complex contact-dependent
intercellular communication that is not only essential for nor-
mal histogenesis but, when dysregulated, also drives malignant
progression and therapeutic resistance.
Small RNAs have a capacity to convey highly specific
sequence-encoded signaling information (15). The microRNA
(miRNA) system plays critical roles in the genesis, progression,
and cytotoxic drug resistance of a range of humanmalignancies
(16). Both the functional complexity of the “miRNome” and the
diversity ofmiRNA targets suggest that regulation of gene func-
tion by miRNAs can be extremely subtle and adaptable (17).
Within the tumor microenvironment, contact-dependent
intercellular communication that is critical to the development
of chemoresistance (18–20) is directly influenced by perturba-
tion of the miRNome (21). This form of intercellular commu-
* This work was supported by Chief Scientist Office Project Grant CZB/4/693
and by the Melville Trust for the Care and Cure of Cancer.
□S This article contains supplemental Figs. S1–S5.
1 Supported by a National Health Service Education Scotland Clinician Scien-
tist Fellowship. Towhomcorrespondence shouldbeaddressed: Pancreatic
Cancer Biology Group, Edinburgh Cancer Research Centre, Western Gen-
eral Hospital, Crewe Rd. S., Edinburgh EH4 2XR, Scotland, United Kingdom.
Tel.: 44-131-7773500; E-mail: mark.duxbury@ed.ac.uk.
2 Theabbreviationsusedare: sysRNAi, systemicRNAi;GJIC, gap junction inter-
cellular communication; SID, systemic RNA interference-defective; tGFP,
turbo green fluorescent protein; AGA, -glycyrrhetinic acid; MTT, 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; CAM-DR, cell
adhesion-mediated drug resistance; PSC, pancreatic stellate cell(s); hPSC,
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nication may represent an opportunity for novel targeted
therapies.
MicroRNA-21 (miR-21), a relatively well characterized
“oncogenic” miRNA, is widely overexpressed in human cancer
and promotes therapeutic resistance in a number of human
cancers (22–25). Pancreatic ductal adenocarcinoma is almost
universally resistant to the nucleoside analog gemcitabine, the
agent that remains themainstay of non-surgical therapy for this
cancer. In vitro, in vivo, and clinical resistance to gemcitabine is
closely associated with levels of miR-21, which targets key apo-
ptotic regulators (e.g. p53, PTEN (phosphatase and tensin hom-
olog), Akt, and repressors of Ras signaling) (26, 27). An
improved understanding of the mechanisms through which
miRNAs drive chemoresistance will guide the development of
urgently needed novel approaches that may increase the effi-
cacy of existing cytotoxic agents, such as gemcitabine. Here we
show that, by mediating rapid contact-dependent intercellular
transfer of small RNAs, SIDT1 facilitates non-cell-autonomous
sequence-specific gene silencing in human cells and can influ-
ence the development of chemoresistance in human adenocar-
cinoma cell populations.
EXPERIMENTAL PROCEDURES
Cell Culture and Reagents—Human HEK293 and BxPC3
cells were purchased from the American Type Culture Collec-
tion (ATCC, Teddington, UK) and maintained as described
previously (28). Gemcitabine (Lilly) and 18--glycerretinic acid
(Sigma) were dissolved in phosphate-buffered saline (PBS).
RNase blend (Cambio) pretreatment was performed using 5
units at 37 °C for 30 min. Trypsinization using 0.25% trypsin
with EDTA (Invitrogen) was stopped by the addition of com-
pletemediumcontaining 10% fetal bovine serum (FBS).Human
pancreatic stellate cells were obtained from surgical resection
specimens under the ethically approved Edinburgh Pancreatic
Biorepository scheme, using the outgrowth technique, detailed
elsewhere (29).
Stable Far Red Membrane Linker—Cell surface labeling was
performed in accordance with the manufacturer’s instructions
(Sigma). In brief, 106 cells were washed in PBS, and the pellet
was resuspended in 1 ml of Diluent C in a 15-ml tube. Fluores-
cent CellVue Claret lipophilic probe was diluted at a final con-
centration of 3 M in 1 ml of Diluent C in a 15-ml tube, and the
solution was rapidly added to cells and incubated for 5 min at
room temperature with occasional agitation. 2 ml of FBS was
added, and after 1min of incubation at room temperature, cells
were washed three times in complete culture medium.
shRNA, Oligonucleotides, Plasmids, and Transfection and
Electroporation—pCMV6-AC, pCMV6-AC-tGFP, pCMV6-
AC-tGFP-SIDT1 (NM_017699), and pCMV6-Connexin-43/
GJA1 (NM_000165) plasmids originated from Origene. Turbo
green fluorescent protein (tGFP) was excised by NotI/PmeI
digestion, fill-in, and ligation to derive pCMV-AC-SIDT1.
Virus-incompetent pTRIPZ-based shRNA vectors (Open Bio-
systems) were used for microRNA expression. A miR-21 dual
luciferase reporter construct was engineered using oligonu-
cleotides designed to include SgfI and PmeI sites (see Table 1
for oligonucleotide sequences). A miR-21-resistant single
base mismatch insert served as a control. Oligonucleotides
were directionally cloned into the corresponding sites of the
psiCHECK2 vector (Promega), in accordance with the man-
ufacturer’s protocol. Renilla luciferase substrate lumines-
cence was normalized to that of firefly luciferase substrate to
allow quantification of Renilla luciferase-miR-21 target
sequence mRNA degradation by miR-21. The Dual-Glo
luciferase assay system (Promega) was read using a VIC-
TOR3-1420 multilabel reader (PerkinElmer Life Sciences).
Transfection was performed using Lipofectamine 2000
(Invitrogen) according to the manufacturer’s protocol. Sta-
ble cell lines were derived using G418 (0.3 mg/ml) or puro-
mycin (5 g/ml; both from Sigma) selection, as appropriate.
All constructs were verified by sequencing. SIDT1-specific
siRNA and mismatch control and Cy3-siRNA (supplemental
material) were obtained from Dharmacon, Sigma, and Euro-
gentec. Lucifer yellow introduction was performed by elec-
troporation in accordance with the manufacturer’s cell type-
specific protocols using the NucleofectorTM system (Lonza).
Gap junction intercellular communication was quantified by
flow cytometric quantification of Lucifer yellow transfer as
described previously (30). Recipient cells were labeled with
far red membrane linker as described above.
Direct Coculture and Flow Cytometric Analysis of Intercellu-
lar siRNA Transfer—Cocultured labeled cell subpopulations
were encouraged to conjugate by centrifugation at 500 rpm for
1min and cocultured at 37 °C or 4 °C. Following coculture, cells
were washed and resuspended in 5mM EDTA/PBS and kept on
ice. Multiparametric flow cytometry data were obtained from
10,000 single cell eventswith stringent doublet exclusion gating
FACSAriaTM II using FACSDiva software (BD Biosciences).
Flow cytometry data were analyzed using FlowJoV8 (TreeStar).
Viable single cells were identified based on forward scatter and
side scatter characteristics (width, height, and area).
TABLE 1
Oligonucleotide sequences
Oligonucleotide Sequence
miR-21 5-UAGCUUAUCAGACUGAUGUUGA-3
miR-21 reporter oligonucleotides 5-CGCAGTAGAGCTCTAGTTCAACATCAGTCTGATAAGCTAGTTT-3
5-AAACTAGCTTATCAGACTGATGTTGAACTAGAGCTCTACTGCGAT-3.
miR-21-resistant single-base mismatch control oligonucleotides 5-GCAGTAGAGCTCTAGTTCAACATCAGAAGATAAGCTAGTTT-3
5-AAACTAGCTTATCTTCTGATGTTGAACTAGAGCTCTACTGCGAT-3.
SIDT1-specific siRNA 1 target sequence 5-CUCUCAGGAUGAACGUAUU-3
SIDT1-specific siRNA 2 target sequence 5-CUACUGGGAUAGAUGUUUU-3
SIDT1-specific siRNA 3 target sequence 5-GAGCAAUUAUGGGACAAUAUU-3
Cy3/control siRNA 5-UAGCGACUAAACACAUCAAUU-3
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Indirect Transwell Coculture and Conditioned Medium—
Upper or lower compartments of each Transwell chamber
(0.4-m pore diameter, 12-well format) were populated with
cells at the specified ratios, in accordance with themanufactur-
er’s instructions (Corning). Cells were incubated for the speci-
fied times at 37 °C, collected using 5 mM EDTA/PBS, and ana-
lyzed for Cy3-siRNA acquisition by flow cytometry, as
described above.
Immunoblotting and Antibodies—Cell extracts and gels were
prepared and used as previously described (28). Goat anti-
SIDT1 polyclonal antibody was obtained from Cambridge Bio-
Science, rabbit anti-SIDT1 polyclonal and anti--smoothmus-
cle actinmonoclonal antibodieswere obtained fromSigma, and
mouse anti--actin monoclonal antibody was obtained from
AbCam. Signal intensities were quantified and normalized to
that of -actin. Blots were performed in triplicate. Mean den-
sitometric values S.D. are shown.
Proliferation, Cytotoxicity, Colony Formation, and Apoptosis
Assays—Cellular proliferation and cytotoxic effects of gemcit-
abine were quantified using the 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) assay (Trevigen,
Gaithersburg, MD), as described previously (31). MTT corre-
lates closely with [3H]thymidine incorporation in pancreatic
cancer cell lines (32). Gemcitabine-induced cytotoxicity was
determined after 24 h of exposure. Plates were read at a wave-
length of 570 nm, corrected to 560 nm, and normalized to con-
trols. Readings were obtained from four biological replicates,
with 10 determinations for each condition tested. The concen-
tration of gemcitabine required to inhibit cellular proliferation
by 50% (IC50) was calculated using Microsoft Excel software
with semilog curve fitting regression analysis. Caspase 3 activity
was quantified using the ApoTarget colorimetric assay in
accordance with the manufacturer’s protocol. Relative absorb-
ance at 405 nmwas quantified using a VICTOR3-1420 multila-
bel reader (PerkinElmer Life Sciences). Apoptotic cells were
quantified by fluorescent terminal deoxynucleotidyltrans-
ferase-mediated nick end labeling, as described previously (33).
Colony formation in the presence of 1 M gemcitabine was
quantified as described elsewhere (34) following Giemsa stain-
ing. tGFP was quantified using a microplate reader (excitation,
485 nm; emission, 530 nm), as described elsewhere (27). tGFP
was normalized to MTT A560 with background subtraction.
RESULTS
Analysis of Stable HEK293-derived Transfectant Cell
Lines—HEK293 cells were transfected with pCMV-based plas-
mids encoding SIDT1 alone or in combination with tGFP and
the aminoglycoside 3-phosphotransferase neomycin resis-
tance selection marker. Levels of SIDT1 expression were quan-
tified byWestern blotting in the following stable transfectants,
which were derived using G418 selection: HEKSIDT1, which
overexpresses SIDT1; HEKSIDT1/tGFP, which overexpresses
SIDT1 and tGFP; and HEKSIDT1-tGFP, which overexpresses a
fusion protein comprising SIDT1 and C terminus tGFP. Stable
tGFP (HEKtGFP) and empty vector transfectants (HEKVector)
served as controls. The electrophoreticmigration of SIDT1 and
SIDT1-tGFP fusion protein was consistent with predicted
respective molecular masses of 94 and 120 kDa (Fig. 1a). The
transfectant cell lines demonstrated no significant differences
in respective rates of cellular proliferation or fraction of apo-
ptotic cells (TUNEL) under standard culture conditions (sup-
plemental Fig. S1).
SIDT1 Facilitates Rapid Contact-dependent siRNA Transfer
between Human Cells—A direct coculture assay was used to
investigate the role of SIDT1 in contact-dependent siRNA
transfer. “Donor” (HEKSIDT1 or HEKVector) and “acceptor”
(HEKSIDT1/tGFP or HEKtGFP) cell subpopulations were sub-
jected to direct coculture, allowing cell-cell contact as schema-
tized (Fig. 1b). Cy3-labeled 21-mer siRNA was introduced into
donor cells by electroporation alone to eliminate potentially
confounding effects of persisting transfection reagent. To mit-
igate against donor epifluorescence signal decay, asmight occur
due to Cy3-siRNA degradation, and to control for trogocytosis
or cell fusion events, donor cells were co-labeled with a far red
fluorescent plasma membrane linker. This linker is highly per-
sistent (t1⁄2 12 days), is biochemically inert, does not affect cell
viability or membrane function, and has an emission spectrum
that is readily distinguishable from that of Cy3 (35–37). Far red
label transfer to unlabeled cells was not observed during any
direct or indirect coculture experiments. Potential artifact aris-
ing from contact-independent medium-borne siRNA transfer
was minimized by postelectroporation washing and RNase
treatment, which degrades extracellular RNA to nucleoside
monophosphates (supplemental Fig. S2a) (38, 39).
SIDT1-overexpressing (HEKSIDT1 and HEKSIDT1/tGFP) and
control (HEKVector andHEKtGFP) donor and acceptor cellswere
cocultured at 1:1 ratios. Following coculture for 90 min, cell
conjugates were disrupted to form single cell suspensions by
EDTA treatment and agitation. Additional RNase treatment
ensured removal of cell surface-associated Cy3-siRNA and free
RNA that may have been released from lysed cells. Intercellular
Cy3-siRNA transfer to acceptor cells was quantified by flow
cytometry using stringent doublet exclusion. We quantified
Cy3-siRNA-positive, tGFP-positive, far red-negative accep-
tor cells, defining a new subset of acceptor cells that had
acquired Cy3-siRNA from donor cells (Fig. 1c, I–VI). Transfer
of Cy3-siRNA between HEKSIDT1 donor and HEKSIDT1/tGFP
acceptor cells was insensitive to RNase treatment and occurred
rapidly (Fig. 1c, VII). In contrast, transfer of Cy3-siRNA
between HEKVector donor and HEKtGFP acceptor cells was neg-
ligible (Fig. 1c, I). Direct coculture using HEKSIDT1 donor and
HEKtGFP acceptor cells (Fig. 1c, II), as well as HEKVector donor
and HEKSIDT1/tGFP acceptor cells (Fig. 1c, III), resulted in no
significant difference in siRNA transfer (i.e. SIDT1 increased
Cy3-siRNA acquisition regardless of whether it was overex-
pressed by donor or acceptor cells, indicating that facilitation of
intercellular siRNA transfer by SIDT1 overexpression is
bidirectional). Transfer of Cy3-siRNA from HEKSIDT1 to
HEKSIDT1/tGFP was abolished by preincubation with polyclonal
anti-SIDT1 (10 g/ml; Fig. 1c, VI).
Although free Cy3-siRNA was eliminated from the culture
medium, we were cognizant that nascent or RNase-resistant
exosome-borne Cy3-siRNA arising from donor cells could also
potentially contribute to the acceptor Cy3-siRNA signal,
through contact-independent acquisition. To control for con-
tact-independent Cy3-siRNA transfer, we performed indirect
SIDT1Mediates Contact-dependent Small RNA Transfer
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coculture of identical donor and acceptor cell groups, separated
by permeable (0.4-m diameter pore) Transwell insert mem-
branes. In addition, acceptor cells were exposed to cell-free
(0.4-m filtered) donor conditioned medium. After either 90
min of indirect coculture or 90 min of exposure to donor con-
ditioned medium, Cy3 epifluorescence was quantified by flow
cytometry, as described above. No transfer of Cy3-siRNA to
either HEKSIDT1/tGFP or HEKtGFP acceptor cells was detected
either following indirect coculturewith donor cells or following
exposure to donor conditioned medium (supplemental Fig.
S2b). Contact-independent uptake of extracellular Cy3-siRNA
therefore did not account for the Cy3 signal acquired by the
acceptor cell subpopulation.
SIDT1-mediated Cy3-siRNA Transfer Is Gap Junction-
independent—The contribution of GJIC to Cy3-siRNA acquisi-
tion was predicted to be small in HEK293 cells, given their low
levels of connexin junction formation and GJIC (40–42). How-
ever, gap junction-mediated intercellular transfer of small RNAs
has been reported in some cell types (43, 44). We therefore took
steps todistinguish the contributionof SIDT1 to the acquisitionof
Cy3-siRNAby acceptor cells from that of GJIC.We reasoned that
enhanced intercellular Cy3-siRNA transfer could result from
either native gap junction-mediated siRNA transfer or facilitation
of GJIC by SIDT1 overexpression.
GJIC was quantified in the direct coculture system by flow
cytometric measurement of Lucifer yellow transfer following
electroporation-mediated Lucifer yellow loading, a quantitative
approach that correlates with the scratch-loading Lucifer yellow
transfer assay (30, 45). Intercellular Lucifer yellow transfer was
minimal in all combinations of HEKSIDT1, HEKSIDT1-tGFP,
HEKSIDT1/tGFP, HEKtGFP, and HEKVector following a 90-min
coculture. GJIC was inhibited without cytotoxicity in all transfec-
FIGURE 1.SIDT1 facilitates rapid contact-dependent intercellular Cy3-siRNA transfer betweendonor andacceptor subpopulations. a, characterization
of SIDT1 protein expression in HEK293-derived stable transfectant cell lines. Shown is representative Western blot analysis of SIDT1 expression in control
HEK293 cells (HEKVector), tGFP control (HEKtGFP), SIDT1 (HEKSIDT1), SIDT1 and tGFP (SIDT1/tGFP, clones 1 and 2), and SIDT1-tGFP fusion (HEKSIDT1-tGFP) transfec-
tants (clones 1–3) and-actin loading control. Electrophoreticmobility of SIDT-1withC-terminal fusion tGFPprotein (SIDT1-tGFP) corresponded to apredicted
molecular mass of 120 kDa versus 94 kDa for SIDT1. b, schematic representation of siRNA transfer coculture experimental design. Donor subpopulations
comprised stableHEKVector orHEKSIDT1 transfectants. Acceptor subpopulations comprisedHEKtGFP orHEKSIDT1/tGFP transfectants. Thedonor subpopulationwas
tagged with far redmembrane linker, and Cy3-siRNAwas introduced by electroporation. Donor and acceptor subpopulations were directly cocultured for 90
min at 37 °C, and single cell suspensions were generated and analyzed by flow cytometry. Quantification of tGFP/Cy3-siRNA/FarRed cells allowed donor
to acceptor Cy3-siRNA transfer to be measured. c, I, in the absence of SIDT1 overexpression, Cy3-siRNA transfer was negligible. II–IV, SIDT1 overexpression
resulted in a marked increase in Cy3-siRNA transfer. SIDT1 overexpression in either donor or acceptor subpopulation was sufficient for this increase in
Cy3-siRNA transfer to occur, indicating that SIDT1 facilitates bidirectional siRNA transfer. V, preincubation with AGA had no effect on Cy3-siRNA transfer
efficiency, indicating the effects of SIDT1 overexpression on Cy3-siRNA transfer to be independent of GJIC. Indirect coculture and conditioned medium
exposure (90 min in each case) did not result in significant acceptor Cy3-siRNA acquisition (supplemental Fig. S3b). VI, Cy3-siRNA transfer was abolished by
preincubation with anti-SIDT1 antibody. VII, time course of Cy3-siRNA transfer from HEKSIDT1 donor to HEKSIDT1/tGFP acceptor cells. Shown is a histogram
representation of tGFP/Cy3-siRNA/FarRed acceptor cells at specified time points. VIII, data presented are typical of quadruplicate biological repeat
experiments. In each sample, 10,000 single cell events were recorded.
SIDT1Mediates Contact-dependent Small RNA Transfer
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tant HEK- and BxPC3-derived cell lines following pretreatment
with the specific small molecule gap junction inhibitor 18--gly-
cyrrhetinic acid (AGA (25 M); supplemental Fig. S3) (46, 47).
Coculture and flowcytometric analysis ofCy3-siRNAtransferwas
repeated following pretreatment with AGA prior to a 90-min
cocultureat37 °C, asdescribedabove.Cy3-siRNAtransferwasnot
significantly affected by AGA. Together, these observations indi-
cate that SIDT1 overexpression does not facilitateGJIC; nor is the
resulting increase inCy3-siRNA transfer dependent on functional
GJIC.
Induction of Non-autonomousmiRNAActivity through Phys-
ical Contact with Subpopulation of miR-21-overexpressing
BxPC3 Cells—miR-21 is a critical driver of resistance to the
nucleoside analog gemcitabine in human pancreatic adenocar-
cinoma, an exemplar of a chemoresistant human malignancy
(26, 27). The humanpancreatic ductal adenocarcinoma cell line
BxPC3 was selected as a model system because it exhibits rela-
tively low levels of miR-21 activity under standard culture con-
ditions (26).
We stably transfected a subpopulation of BxPC3 cells with a
non-viral pTRIPZ-derivedmiR-21 expression construct. These
cells (BxPC3miR21) generate miR-21 in a doxycycline-indu-
cible manner. Irrelevant miRNA-generating transfectants
(BxPC3miRN/S, derived from RHS4346) served as controls. A
miR-21 reporter cell line (BxPC3CkmiR21) was derived from
BxPC3 by stable transfection of a psiCHECK-2-based miR-21
reporter construct. This dual luciferase reporter system allows
Renilla luciferase activity, which decreases in the presence of
miR-21, to be normalized to firefly luciferase, controlling for
variations in reporter construct abundance. A single nucleotide
mismatch reporter cell line (BxPC3CkmiR21 mm) was employed
to confirm the specificity of the reporter system for miR-21
(supplemental Fig. S4).
BxPC3miR21 and BxPC3CkmiR21 cells were subjected to direct
coculture at high total cell density (80–90% cell-cell contact) at
BxPC3miR21/BxPC3CkmiR21 ratios ranging from 1:10 to 1:1000,
in the presence or absence of 1 g/ml doxycycline. Doxycy-
cline-induced BxPC3miR21 activation (confirmed by RFP epi-
fluorescence) led to a decrease in normalized Renilla luciferase
activity of directly cocultured BxPC3CkmiR21 reporter cells,
reflecting increased miR-21 activity within the BxPC3CkmiR21
reporter cell subpopulation. Direct coculture with
BxPC3miRN/S had no effect on normalized Renilla activity of
BxPC3CkmiR21 cells, confirming specificity for the miR-21
sequence. Significant decreases in normalized Renilla lucifer-
ase activity were observed even when BxPC3miR21 cells were
present as a minority of 0.1% (Fig. 2a). This non-autonomous
increase in miR-21 activity within the BxPC3CkmiR21 subpopu-
lation was not observed when BxPC3CkmiR21 cells were sub-
jected to indirect coculturewith BxPC3miR21 cells (0.4-mpore
diameter; Transwell; Fig. 2a).
Non-autonomousmiR-21 Activity Is SIDT1-dependent—Our
previous observations led us to hypothesize that the SIDT1
channel could facilitate miR-21 transfer between contacting
cells. SIDT1 channel protein expression varies considerably
between pancreatic adenocarcinoma and immortalized normal
ductal epithelial cell (HPDE4) lines. Among adenocarcinoma
cells, BxPC3 expresses relatively high levels of SIDT1 (Fig. 2b).
Increased miR-21 activity in BxPC3CkmiR21 induced by the
doxycycline-activatedminority BxPC3miR21 subpopulationwas
abrogated by pretreatment with siRNAs directed against differ-
ent regions of the SIDT1 sequence, including the SIDT1 3-un-
translated region (3-UTR), but not control siRNA (Fig. 3). The
specificity of this siRNA-induced effect was further confirmed
by a “rescue step” in which a SIDT1 expression construct lack-
ing the SIDT1 3-UTR target sequence or empty vector control
FIGURE 2.Aminority subpopulation increases non-autonomousmiR-21 activity in adenocarcinoma cells. a, BxPC3miR21 (doxycycline-inducible miR-21)
or irrelevant miRNA (BxPC3miRN/S) controls were directly cocultured with miR-21 reporter cells (BxPC3CkmiR21) at the indicated ratios (1 g/ml doxycycline).
Renilla luciferase luminescence (levels decreased by miR-21) was normalized to firefly luciferase luminescence to allow quantitative comparison (relative
luminescence units (RLU)). Doxycycline-induced BxPC3miR21 activation increasedmiR-21 activity in BxPC3CkmiR21 reporter cells. Coculture of BxPC3CkmiR21 with
BxPC3miRN/S hadnoeffect onnormalizedRenilla activity in BxPC3CkmiR21. Indirect coculturewas insufficient to inducenon-autonomousmiR-21 activity. The first
white column indicates BxPC3CkmiR21 in standard monoculture. *, p  0.05 versus BxPC3miR21  BxPC3CkmiR21, no doxycycline by multifactorial analysis of
variance, n 4. b, representative Western blot analysis of SIDT1 expression in pancreatic adenocarcinoma (BxPC3, MIAPaCa2, and Capan2) and immortalized
normal ductal epithelial cells (HPDE4), demonstrating differential expression of SIDT1. Densitometric quantification (means S.D. (error bars)) of SIDT1 signal,
normalized to that of -actin. Shown are mean values S.D. (n 3). AU, arbitrary absorbance units.
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was co-transfected with SIDT1–3-UTR siRNA 1. SIDT1 over-
expression “rescued” the abrogation ofmiR-21 induction in the
BxPC3CkmiR21 reporter subpopulation that was observed with
SIDT1–3-UTR siRNA 1 treatment (Fig. 3).
Minority Subpopulation ofmiR-21-overexpressing Adenocar-
cinoma Cells Increases Global Cellular Chemoresistance to
Gemcitabine—Given the ability of a minority subpopulation of
BxPC3miR21 cells to increase miR-21 activity in physically con-
tacting BxPC3CkmiR21 cells, we examined the effect of a 1% sub-
population of BxPC3miR21 on the gemcitabine IC50 for the total
mixed cell population. Cells were exposed to clinically relevant
concentrations of gemcitabine (48–52), and the IC50 was
derived for thewhole cell population. The gemcitabine IC50was
increased from 6  108 to 3  106 M by direct coculture of
doxycycline-activated BxPC3miR21 with BxPC3CkmiR21 cells
(ratio 1:100). Importantly, firefly luciferase activity normalized
to total cell number remained constant, indicating preservation
of the BxPC3miR21/BxPC3CkmiR21 ratio over the duration of the
experiment. The gemcitabine IC50 approximated control levels
when doxycycline was withheld and was unaffected by direct
coculture of BxPC3miRN/S with BxPC3CkmiR21, confirming
specificity of the effect to themiR-21 sequence (Fig. 4a). Trans-
fer of mir-21 and IC50 were unaffected by 25 M AGA (Fig. 4d
and supplemental Fig. S3).
SIDT1 Deficiency Attenuates Chemoresistance Induced by
Minority miR-21-overexpressing Subpopulation of Adenocarci-
nomaCells—The increase in global cellular chemoresistance to
gemcitabine that miR-21 induced was cell contact-dependent,
the IC50 being unaffected when BxPC3miR21 and BxPC3CkmiR21
cells were subjected to indirect coculture (BxPC3miR21/
BxPC3CkmiR21 1:100; Fig. 4b). The miR-21-induced increase
in IC50 was significantly attenuated when cells were treated
with SIDT1–3-UTR siRNA 1 but not control siRNA. A SIDT1
re-expression rescue step, as described above, confirmed that
the decrease in gemcitabine IC50 induced by SIDT1–3-UTR
siRNA 1 could be abolished by restoring levels of SIDT1 (Fig.
4c). Corresponding impairment of colony forming capacity and
increased caspase 3 activities were observed when BXPC3miR21
and BxPC3CkmiR21 were cocultured in the presence of gemcit-
abine following treatment with SIDT1–3-UTR siRNA 1. Rein-
troduction of SIDT1 abolished these effects on colony forma-
tion and caspase activities (Fig. 5).
SIDT1 Contributes to Cell Adhesion-mediated Drug Resis-
tance (CAM-DR)—Given the capacity for small RNA transfer
observed between adenocarcinoma cells, we examinedwhether
a similar process might contribute to the complex tumor-stro-
mal cell interactions that can enhance chemoresistance in a
range of human cancers (53). Human pancreatic stellate cells
(hPSC) were isolated from surgical resection specimens, and
their morphology and immunophenotype (54) were confirmed
(Fig. 6a). SIDT1 was relatively highly expressed in all three
hPSC lines tested (Fig. 6b). We repeated the flow cytometric
Cy3-siRNA transfer assay, as before, and observed rapid
Cy3-siRNA transfer between adenocarcinoma and hPSC cells
thatwas sensitive to anti-SIDT1 antibody treatment (Fig. 6c). In
order to quantify CAM-DR, we subjected BxPC3tGFP cells to
direct coculturewith hPSC in the presence of 1Mgemcitabine
andmeasured tGFP fluorescence, which correlates with adeno-
carcinoma cell number (27), normalizing GFP fluorescence to
MTT-based total cell quantification. BxPC3tGFP proliferation
in the presence of clinically relevant gemcitabine levels was
markedly increased by hPSCcoculture. Furthermore, this effect
was abrogated by treatment with 10 g/ml anti-SIDT1 anti-
body but not control-matched immunoglobulin. Although this
aspect of SIDT1 biology requires further investigation, this
FIGURE 3. SIDT1 is required for intercellularmiR-21 transfer. a, knockdown of SIDT1 expression by siRNAwas quantified byWestern blotting. Three siRNAs
targeting different regions of the SIDT1 sequence were compared. Mean S.D. (error bars) densitometric values are presented (n 3). Levels of SIDT1 were
most effectively decreasedby siRNA1,which targets the 3-UTR, but could be rescuedby co-transfection of the SIDT1 expression vector (which lacks the siRNA
1 3-UTR target) but not by control vector. b, BxPC3CkmiR21 reporter activation by the minority (1%) BxPC3miR21 subpopulation was abrogated by transfection
of siRNA 1 but not control siRNA prior to coculture. SIDT1 rescue restored BxPC3CkmiR21 miR-21 induction despite siRNA 1. Triplicate means S.D. are shown.
SIDT1 signal was normalized to that of -actin. *, p 0.05 versus N/S siRNA; **, p 0.05 versus 3-UTR siRNA 1 vector, by multifactorial analysis of variance
(n 5). RFU, relative fluorescence units.
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result demonstrates that heterotypic intercellular small RNA
transfer can occur and that SIDT1 contributes to this process.
In summary, SIDT1 facilitates rapid bidirectional, con-
tact-dependent, RNase-insensitive transfer of Cy3-siRNA
that is independent of GJIC. Contact-independent siRNA
transfer was insignificant in comparison with SIDT1-medi-
ated contact-dependent Cy3-siRNA acquisition. SIDT1-de-
pendent Cy3-siRNA intercellular transfer is not restricted to
adenocarcinoma cells and can occur between stromal cells,
influencing CAM-DR.
DISCUSSION
Although organism-wide sysRNAi is not apparent in mam-
mals, significant phylogenetic molecular conservation suggests
that sysRNAi pathways may be relevant to human physiology
and pathophysiology (7). The C. elegans orthologue of SIDT1,
SID1, has recently been shown to be a dsRNA-gated channel
capable of selective bidirectional intercellular dsRNA transfer
(11). Our findings demonstrate first that SIDT1 facilitates con-
tact-dependent small RNA transfer and non-cell-autonomous
posttranscriptional regulation; second, they support the asser-
tion that small RNA-based signaling represents a further level
of adaptive capacity and complexity within the tumormicroen-
vironment; and third, they indicate that disruption or exploita-
tion of sysRNAi pathways may have therapeutic utility, partic-
ularly as a means of impairing the acquisition of resistance to
cytotoxic agents.
Contact-dependent intercellular communication not only
maintains normal tissue organization but can also drive neopla-
sia. However, to date, studies of SID family proteins have gen-
erally focused on these proteins as conduits for the contact-
independent uptake of free small RNAs from the extracellular
milieu (12, 13). In addition to characterizing the role of SIDT1
in the context of contact-dependent small RNA intercellular
transfer, this study provides new evidence that contact-depen-
dent non-cell-autonomous RNAi can shape therapeutic resis-
tance in pancreatic cancer and that SIDT1 can act as amediator
of this form of RNA-based intercellular communication.
The miRNome is a highly complex and adaptable system,
with each miRNA exerting pleiotropic effects. Recent studies
illustrate miRNA biogenesis to be exquisitely sensitive to cell
context, miRNA levels increasing in a contact-dependent man-
ner (55).miR-21was the focus of this study because it promotes
chemoresistance to gemcitabine in human adenocarcinoma
cells (22–25). The ability of a minority subpopulation of miR-
21-overexpressing cells to influence global chemoresistance
through a contact-mediated, SIDT1-dependent mechanism
raises the intriguing possibility that subgroups of cells within a
FIGURE4.SIDT1deficiencyabrogates chemoresistance inducedbyaminoritymiR-21-expressing subpopulationofpancreatic adenocarcinomacells.
Chemoresistance was quantified by MTT assay, and IC50 values were derived. a, the IC50 of gemcitabine was significantly increased by direct coculture of
doxycycline-activated BxPC3miR21 with BxPC3CkmiR21 cells (ratio 1:100). b, the alteration in IC50 was minimal when the minority subpopulation was indirectly
cocultured (Transwell). The gemcitabine IC50 was unaffected by coculture of BxPC3
miRN/S with BxPC3CkmiR21. Means S.D. (error bars) are presented (n 3).
c, the increase in IC50 induced bymiR-21was attenuatedwhen cells were treatedwith SIDT1–3-UTR siRNA 1 but not by control mismatch siRNA. SIDT1 rescue
abrogated the effect of SIDT1–3-UTR siRNA 1. d, gap junction inhibition using 25 M AGA did not significantly affect the increase in IC50 induced by miR-21.
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heterogeneous tumor population can influence resistance
within the wider tumor microenvironment through contact-
dependent non-cell-autonomous RNAi. Subpopulations of
drug-tolerant tumor cells employ dynamic survival strategies
that result in therapeutic resistance (34). Parallels can be drawn
with microbial resistance, in which a small number of tolerant
organisms can influence the “fitness” of the populations as a
whole. Similarly, cells exposed to cytotoxic drug may, through
small RNA-based communication, influence survival pathways
within contacting cells over significant distances.
The rapid nature of SIDT1-mediated small RNA transfer is
particularly striking and significantly precedesRNA transfer via
contact-independent mechanisms, such as exosomal shuttling
and free RNA transfer (38). Tumor cells that are capable of
rapid adaptation are more likely to gain selective advantage in
the presence of a toxic perturbation. Rapid small RNA transfer
and resulting posttranscriptional gene regulation would allow
more timely adaptive changes than those resulting from “clas-
sic” genetic mutation. This study supports the premise that
small RNAs have the capacity to act as signaling intermediaries.
The absence of disseminating fluorescent protein expression to
acceptor cells in longer term coculture studies confirms a
degree of RNA type and size specificity (i.e. SIDT1 does not
facilitate functional mRNA transfer). These observations are in
keeping with the relative specificity for dsRNA exhibited by
SID1 (11).
Our results demonstrate SIDT1-mediated siRNA transfer to
be independent of GJIC. GJIC can increase the susceptibility of
cancer cells to cytotoxic agents through connexin-mediated
“bystander effects” in pancreatic cancer (56). BxPC3 cells in
which GJIC is artificially increased exhibit bystander cytotox-
icity when exposed to gemcitabine (56–58). Interestingly, con-
nexin expression and GJIC are frequently decreased in cancer,
re-expression of connexins commonly suppressing tumorige-
nicity (59). In contrast to the relatively non-selective nature of
connexin-mediated communication, SIDT1 overexpression
does not increase Lucifer yellow transfer. SIDT1may therefore
represent a means by which tumor cells can adapt to maintain
small RNA-based intercellular communication, without expe-
riencing greater bystander cytotoxicity that increased GJIC
would incur.
Recent data from other groups indicate that non-cell-auton-
omous small RNA effectsmay be of general relevance to human
cancer. Katakowski et al. (60) reported microvesicle-indepen-
dent microRNA transfer between U87 human glioma cells.
Although this study did not directly examine chemoresistance,
the authors demonstrated non-autonomous microRNA effects
in contacting cells. Zhao et al. (61) have demonstrated that
SNB19 glioma cells can undergo intercellular transfer of PTEN-
silencing siRNA in coculture. Interestingly, this effect was only
observed in direct (contact-dependent) but not indirect (con-
tact-independent) coculture. The PTEN tumor suppressor
mRNA is a target ofmiR-21 and a number of othermicroRNAs.
PTEN deficiency is clinically associated with chemoresistance
in a range of human cancers. These data also suggest that non-
autonomous gene silencing can result in molecular events that
promote clinical chemoresistance.
We have demonstrated that SIDT1-dependent small RNA
transfer can also operate between adenocarcinoma and stromal
cells, in this case pancreatic stellate cells. The important che-
moprotective effects of direct tumor-stromal cell contact are
increasingly recognized (27). CAM-DR that develops in the
tumor microenvironment may represent a future therapeutic
opportunity. Follicular dendritic cells can protect B-cell lym-
phoma cells fromdrug-induced apoptosis through contact-me-
diated microRNA-dependent mechanisms (21, 62). miR-181a
was found to be increased by direct contact between dendritic
and lymphoma cells but not when cells were cultured under
indirect coculture conditions, suggesting that free RNA, RNA
bound to proteins (e.g.Argonaute or lipoproteins), or exosomal
RNA transfer is less likely to mediate the effects on chemore-
sistance in this setting. This is in keepingwith our observations.
Although the possibility that the non-autonomous increase in
miR-181a levels could result from intercellular RNA transfer
was not explored, interestingly, SIDT1 is also relatively overex-
pressed in dendritic cells.
The clinical implications of SIDT1 expression levels are likely
to be complex and will be influenced by the prevailing miR-
Nome within the tumor. Preliminary studies of primary breast
cancer mRNA and microRNA expression arrays are consistent
with the hypothesis that SIDT1may have a “permissive” role in
some of the phenotypic effects of miR-21 overexpression. High
levels ofmiR-21 expression result in poorer survival for patients
with SIDT1-overexpressing tumors relative to those with low
SIDT1 expression (supplemental Fig. S5). Further clinical stud-
ies are ongoing to address this question.
FIGURE 5. SIDT1 knockdown abrogates miR-21-induced chemoresis-
tance. a, caspase 3 activities were quantified 24 h following exposure to 1M
gemcitabine by a colorimetric caspase 3 assay. Relative absorbances at 405
nm with background subtraction are presented. Mean values  S.D. (error
bars) from four biological replicates are shown. b, representative images of
colony formation capacity for each condition.
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In conclusion, SIDT1 mediates contact-dependent siRNA
and miRNA transfer and non-cell-autonomous RNAi, which
can enhance pancreatic adenocarcinoma chemoresistance to
gemcitabine that is driven by miR-21. SIDT1-dependent small
RNA transfer may also contribute to CAM-DR. Although sys-
RNAi in humans appears not to be the organism-wide phenom-
enon observed in C. elegans, comparable processes may sup-
port adaptation to perturbations and selective pressures within
the tumor microenvironment, such as those induced by cyto-
toxic therapy. Therapeutic exploitation of sysRNAi pathways
may have utility in human cancer and warrants further experi-
mental evaluation.
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